Enantiomeric resolution of novel aryloxyaminopropanol derivatives with P-adrenoceptor antagonist activity on a derivatised amylose chiral stationary phase

J Valentova, R Cizmarikova, T T T Bui, A F Drake, A J Hutt

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

The chromatographic retention and resolution of the enantiomers of a novel series of aryl-oxyaminopropanol derivatives with beta-adrenoceptor antagonist activity have been investigated using a Chiralpak AD CSP. The influence of mobile phase composition, particularly alcohol modifier content and composition, on analyte retention and separation were determined; the final composition being hexane: ethanol: methanol:diethylamine (85:3.75:11.25:0.1% by Volume). Analyte structure, including the position and nature of the aromatic substituents, steric bulk of the nitrogen alkyl substituent and length and bulk of the side chain were found to influence both retention and chiral discrimination. Semi-preparative isolation of the enantiomers of two of the compounds, followed by CD analysis of complexes formed on reaction with molybdenum tetraocetate, indicated that the enantiomeric elution order for both compounds was the same as that of propronolol, i.e. R- before S-.
Original languageEnglish
Pages (from-to)733 - 740
Number of pages8
JournalCHROMATOGRAPHIA
Volume58
Issue number11-12
DOIs
Publication statusPublished - 2003

Fingerprint

Dive into the research topics of 'Enantiomeric resolution of novel aryloxyaminopropanol derivatives with P-adrenoceptor antagonist activity on a derivatised amylose chiral stationary phase'. Together they form a unique fingerprint.

Cite this